Must Psilocybin Always “Assist Psychotherapy”?
American Journal of Psychiatry · 01.01.2024 · 181 (1) · 20-25
DOI: 10.1176/appi.ajp.20221043 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Psychiatry, erschienen am 01.01.2024. Verfasst von Guy M Goodwin und 3 weiteren Autor:innen. Beteiligte Einrichtung: COMPASS Pathways Plc, London (Goodwin, Malievskaia); Department of Psychiatry and Behavioral Sciences, University of Texas at Austin Dell Medical Sch…. Hauptthemen laut MEDLINE: Psilocybin, Hallucinogens. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- COMPASS Pathways Plc, London (Goodwin, Malievskaia); Department of Psychiatry and Behavioral Sciences, University of Texas at Austin Dell Medical School, Austin (Fonzo, Nemeroff).
Zitieren
APA
Goodwin, G. M., Malievskaia, E., Fonzo, G. A., & Nemeroff, C. B. (2024). Must Psilocybin Always “Assist Psychotherapy”?. American Journal of Psychiatry, 181(1), 20-25. https://doi.org/10.1176/appi.ajp.20221043
Vancouver
Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB. Must Psilocybin Always “Assist Psychotherapy”?. American Journal of Psychiatry. 2024;181(1):20-25. doi:10.1176/appi.ajp.20221043
BibTeX
@article{Goodwin2024,
author = {Goodwin, Guy M and Malievskaia, Ekaterina and Fonzo, Gregory A and Nemeroff, Charles B},
title = {Must Psilocybin Always “Assist Psychotherapy”?},
journal = {American Journal of Psychiatry},
year = {2024},
volume = {181},
number = {1},
pages = {20--25},
doi = {10.1176/appi.ajp.20221043}
}
EUVIMED